Crosstalk between protein kinase A and growth factor receptor signaling pathways in arterial smooth muscle.

[1]  J. Lawrence,et al.  Attenuation of Mammalian Target of Rapamycin Activity by Increased cAMP in 3T3-L1 Adipocytes* , 1998, The Journal of Biological Chemistry.

[2]  A M Graybiel,et al.  A family of cAMP-binding proteins that directly activate Rap1. , 1998, Science.

[3]  A. Wittinghofer,et al.  Epac is a Rap1 guanine-nucleotide-exchange factor directly activated by cyclic AMP , 1998, Nature.

[4]  J. Woodgett,et al.  Phosphoinositide-3-OH kinase-dependent regulation of glycogen synthase kinase 3 and protein kinase B/AKT by the integrin-linked kinase. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[5]  R. Tuder,et al.  Role of adenylyl cyclase in proliferation of neonatal pulmonary artery smooth muscle cells. , 1998, Chest.

[6]  R. Roth,et al.  Evidence of insulin-stimulated phosphorylation and activation of the mammalian target of rapamycin mediated by a protein kinase B signaling pathway. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[7]  S. Desrivières,et al.  Rapamycin Inhibition of the G1 to S Transition Is Mediated by Effects on Cyclin D1 mRNA and Protein Stability* , 1998, The Journal of Biological Chemistry.

[8]  P. Klatt,et al.  Defective smooth muscle regulation in cGMP kinase I‐deficient mice , 1998, The EMBO journal.

[9]  Eric R Kandel,et al.  Identification of a Gene Encoding a Hyperpolarization-Activated Pacemaker Channel of Brain , 1998, Cell.

[10]  M. Davies,et al.  Pervanadate inhibits mitogen‐activated protein kinase kinase‐1 in a p38MAPK‐dependent manner , 1998, FEBS letters.

[11]  T. Haystead,et al.  Acceleration of Myosin Light Chain Dephosphorylation and Relaxation of Smooth Muscle by Telokin , 1998, The Journal of Biological Chemistry.

[12]  J. Yates,et al.  Primary Structure and Function of an A Kinase Anchoring Protein Associated with Calcium Channels , 1998, Neuron.

[13]  E. Mccleskey,et al.  Rap1 mediates sustained MAP kinase activation induced by nerve growth factor , 1998, Nature.

[14]  J. Downward.  Mechanisms and consequences of activation of protein kinase B/Akt. , 1998, Current opinion in cell biology.

[15]  M. Houslay,et al.  Stimulation of p70S6 kinase via a growth hormone-controlled phosphatidylinositol 3-kinase pathway leads to the activation of a PDE4A cyclic AMP-specific phosphodiesterase in 3T3-F442A preadipocytes. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[16]  J. Hamilton,et al.  cAMP enhances CSF-1-induced ERK activity and c-fos mRNA expression via a MEK-dependent and Ras-independent mechanism in macrophages. , 1998, Biochemical and biophysical research communications.

[17]  R. Wojcikiewicz,et al.  Phosphorylation of Inositol 1,4,5-Trisphosphate Receptors by cAMP-dependent Protein Kinase , 1998, The Journal of Biological Chemistry.

[18]  D. Mukhopadhyay,et al.  Modulation of Voltage-dependent Ca2+Channels in Rabbit Colonic Smooth Muscle Cells by c-Src and Focal Adhesion Kinase* , 1998, The Journal of Biological Chemistry.

[19]  R. Mertelsmann,et al.  The JAK-STAT pathway: signal transduction involved in proliferation, differentiation and transformation. , 1998, Leukemia & lymphoma.

[20]  J. Michel,et al.  Regulation of vascular endothelial growth factor expression by cAMP in rat aortic smooth muscle cells. , 1998, Experimental cell research.

[21]  S. Mittnacht,et al.  Control of pRB phosphorylation. , 1998, Current opinion in genetics & development.

[22]  M. Andjelkovic,et al.  Phosphorylation and activation of p70s6k by PDK1. , 1998, Science.

[23]  Dario R. Alessi,et al.  3-Phosphoinositide-dependent protein kinase 1 (PDK1) phosphorylates and activates the p70 S6 kinase in vivo and in vitro , 1998, Current Biology.

[24]  I. Zachary,et al.  Vascular endothelial growth factor stimulates prostacyclin production and activation of cytosolic phospholipase A2 in endothelial cells via p42/p44 mitogen‐activated protein kinase , 1997, FEBS letters.

[25]  S. Pyne,et al.  Bradykinin stimulates cAMP synthesis via mitogen-activated protein kinase-dependent regulation of cytosolic phospholipase A2 and prostaglandin E2 release in airway smooth muscle. , 1997, The Biochemical journal.

[26]  E. Nishio,et al.  Nitric oxide donor-induced apoptosis in smooth muscle cells is modulated by protein kinase C and protein kinase A. , 1997, European journal of pharmacology.

[27]  E. Krebs,et al.  Calmodulin-stimulated cyclic nucleotide phosphodiesterase (PDE1C) is induced in human arterial smooth muscle cells of the synthetic, proliferative phenotype. , 1997, The Journal of clinical investigation.

[28]  G. Nickenig,et al.  The vascular smooth muscle type I angiotensin II receptor mRNA is destabilized by cyclic AMP-elevating agents. , 1997, Molecular pharmacology.

[29]  J. Yoshikawa,et al.  Dopamine as a novel antimigration and antiproliferative factor of vascular smooth muscle cells through dopamine D1-like receptors. , 1997, Arteriosclerosis, thrombosis, and vascular biology.

[30]  G. Baumann,et al.  Regulation of Tumor Necrosis Factor-α and Interleukin-1β Induced Adhesion Molecule Expression in Human Vascular Smooth Muscle Cells by cAMP , 1997 .

[31]  S. Meloche,et al.  Cyclic AMP-mediated Inhibition of Angiotensin II-induced Protein Synthesis Is Associated with Suppression of Tyrosine Phosphorylation Signaling in Vascular Smooth Muscle Cells* , 1997, The Journal of Biological Chemistry.

[32]  M. Kasuga,et al.  Regulation of eIF-4E BP1 Phosphorylation by mTOR* , 1997, The Journal of Biological Chemistry.

[33]  X. Wang,et al.  The antiproliferative effects of calcitonin gene-related peptide in different passages of cultured vascular smooth muscle cells , 1997, Neuropeptides.

[34]  Colin B. Reese,et al.  3-Phosphoinositide-dependent protein kinase-1 (PDK1): structural and functional homology with the Drosophila DSTPK61 kinase , 1997, Current Biology.

[35]  M. Bryckaert,et al.  Regulatory role of prostaglandin E2 in induction of cyclo-oxygenase-2 by a thromboxane A2 analogue (U46619) and basic fibroblast growth factor in porcine aortic smooth-muscle cells. , 1997, The Biochemical journal.

[36]  E. Krebs,et al.  The mitogen-activated protein kinase pathway can mediate growth inhibition and proliferation in smooth muscle cells. Dependence on the availability of downstream targets. , 1997, The Journal of clinical investigation.

[37]  P. Vadiveloo,et al.  G1 phase arrest of human smooth muscle cells by heparin, IL-4 and cAMP is linked to repression of cyclin D1 and cdk2. , 1997, Atherosclerosis.

[38]  G. Condorelli,et al.  Activation of cAMP–PKA signaling in vivo inhibits smooth muscle cell proliferation induced by vascular injury , 1997, Nature Medicine.

[39]  X Wang,et al.  Activation of translation initiation factor eIF2B by insulin requires phosphatidyl inositol 3‐kinase , 1997, FEBS letters.

[40]  R. Pearson,et al.  Rapamycin suppresses 5′TOP mRNA translation through inhibition of p70s6k , 1997, The EMBO journal.

[41]  R. Idzerda,et al.  PKA isoforms, neural pathways, and behaviour: making the connection , 1997, Current Opinion in Neurobiology.

[42]  W. Lowe,et al.  Growth factor-induced transcription via the serum response element is inhibited by cyclic adenosine 3',5'-monophosphate in MCF-7 breast cancer cells. , 1997, Endocrinology.

[43]  J. Scott,et al.  Protein Kinase A Anchoring* , 1997, The Journal of Biological Chemistry.

[44]  S. Pyne,et al.  Platelet-derived growth factor activates a mammalian Ste20 coupled mitogen-activated protein kinase in airway smooth muscle. , 1997, Cellular signalling.

[45]  H. Yao,et al.  cAMP Activates MAP Kinase and Elk-1 through a B-Raf- and Rap1-Dependent Pathway , 1997, Cell.

[46]  J. Beavo,et al.  Attenuation of insulin secretion by insulin-like growth factor 1 is mediated through activation of phosphodiesterase 3B. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[47]  J. Gutkind,et al.  Requirement of phosphatidylinositol-3 kinase for activation of JNK/SAPKs by PDGF. , 1997, Biochemical and biophysical research communications.

[48]  M. Rekhter,et al.  The growth of human atherosclerosis: Cell proliferation and collagen synthesis , 1997 .

[49]  Y. Ishikawa,et al.  The adenylyl cyclases as integrators of transmembrane signal transduction. , 1997, Circulation research.

[50]  R. Buscà,et al.  Inhibition of the Phosphatidylinositol 3-Kinase/p70S6-Kinase Pathway Induces B16 Melanoma Cell Differentiation* , 1996, The Journal of Biological Chemistry.

[51]  James M. Roberts,et al.  Fibrillar Collagen Inhibits Arterial Smooth Muscle Proliferation through Regulation of Cdk2 Inhibitors , 1996, Cell.

[52]  T. Nakai,et al.  Effects of glucose, insulin, and insulin-like growth factor-I on glucose transport activity in cultured rat vascular smooth muscle cells , 1996 .

[53]  M. Kasuga,et al.  Phosphatidylinositol 3-Kinase-independent Signal Transduction Pathway for Platelet-derived Growth Factor-induced Chemotaxis* , 1996, The Journal of Biological Chemistry.

[54]  P. Janosch,et al.  Negative regulation of Raf-1 by phosphorylation of serine 621 , 1996, Molecular and cellular biology.

[55]  C. Carter-Su,et al.  Signalling pathway of GH. , 1996, Endocrine journal.

[56]  A. Peacock,et al.  A regulatory role for cAMP in phosphatidylinositol 3-kinase/p70 ribosomal S6 kinase-mediated DNA synthesis in platelet-derived-growth-factor-stimulated bovine airway smooth-muscle cells. , 1996, The Biochemical journal.

[57]  M. Runge,et al.  Cyclic AMP Inhibition of Thrombin-induced Growth in Vascular Smooth Muscle Cells Correlates with Decreased JNK1 Activity and c-Jun Expression* , 1996, The Journal of Biological Chemistry.

[58]  Michael E. Greenberg,et al.  Coupling of the RAS-MAPK Pathway to Gene Activation by RSK2, a Growth Factor-Regulated CREB Kinase , 1996, Science.

[59]  S. Meloche,et al.  Inhibition of Growth Factor-induced Protein Synthesis by a Selective MEK Inhibitor in Aortic Smooth Muscle Cells* , 1996, The Journal of Biological Chemistry.

[60]  J. Jeffrey,et al.  Serotonin regulation of gene expression in uterine extracellular matrix: reciprocal effects on collagens and collagenase , 1996, Molecular and Cellular Endocrinology.

[61]  J. Pouysségur,et al.  cAMP-mediated Growth Inhibition in Fibroblasts Is Not Mediated via Mitogen-activated Protein (MAP) Kinase (ERK) Inhibition , 1996, The Journal of Biological Chemistry.

[62]  T. Kaji,et al.  Cyclic AMP-dependent pathway that mediates suppressive regulation of glycosaminoglycan production in cultured vascular endothelial cells. , 1996, Thrombosis research.

[63]  J. Blenis,et al.  The 70 kDa S6 Kinase Complexes with and Is Activated by the Rho Family G Proteins Cdc42 and Rac1 , 1996, Cell.

[64]  C. Proud.  p70 S6 kinase: an enigma with variations. , 1996, Trends in biochemical sciences.

[65]  M. Vignais,et al.  Platelet-derived growth factor induces phosphorylation of multiple JAK family kinases and STAT proteins , 1996, Molecular and cellular biology.

[66]  L. Claesson‐Welsh,et al.  Requirement for Phosphatidylinositol 3′-Kinase Activity in Platelet-derived Growth Factor-stimulated Tyrosine Phosphorylation of p125 Focal Adhesion Kinase and Paxillin (*) , 1996, The Journal of Biological Chemistry.

[67]  M. David,et al.  Activation of Protein Kinase A Inhibits Interferon Induction of the Jak/Stat Pathway in U266 Cells (*) , 1996, The Journal of Biological Chemistry.

[68]  R. Alexander,et al.  Endothelial control of the cardiovascular system: recent advances , 1996, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[69]  Ravi Iyengar.  Gating by Cyclic AMP: Expanded Role for an Old Signaling Pathway , 1996, Science.

[70]  E. Krebs,et al.  Platelet-derived Growth Factor Stimulates Protein Kinase A through a Mitogen-activated Protein Kinase-dependent Pathway in Human Arterial Smooth Muscle Cells (*) , 1996, The Journal of Biological Chemistry.

[71]  P. Cohen,et al.  Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B , 1995, Nature.

[72]  C. Benjamin,et al.  Activation of thromboxane and prostacyclin receptors elicits opposing effects on vascular smooth muscle cell growth and mitogen-activated protein kinase signaling cascades. , 1995, Molecular pharmacology.

[73]  T. Hunter,et al.  When is a lipid kinase not a lipid kinase? When it is a protein kinase , 1995, Cell.

[74]  R. Pearson,et al.  Rapamycin, Wortmannin, and the Methylxanthine SQ20006 Inactivate p70s6k by Inducing Dephosphorylation of the Same Subset of Sites (*) , 1995, The Journal of Biological Chemistry.

[75]  H. Bourne,et al.  Differential effects on cAMP on the MAP kinase cascade: evidence for a cAMP-insensitive step that can bypass Raf-1. , 1995, Molecular biology of the cell.

[76]  E. Krebs,et al.  cAMP- and rapamycin-sensitive regulation of the association of eukaryotic initiation factor 4E and the translational regulator PHAS-I in aortic smooth muscle cells. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[77]  A. Sharrocks,et al.  Integration of MAP kinase signal transduction pathways at the serum response element. , 1995, Science.

[78]  E. Degerman,et al.  Type III cGMP-inhibited cyclic nucleotide phosphodiesterases (PDE3 gene family). , 1995, Cellular signalling.

[79]  E. Krebs,et al.  Sphingosine-1-phosphate inhibits PDGF-induced chemotaxis of human arterial smooth muscle cells: spatial and temporal modulation of PDGF chemotactic signal transduction , 1995, The Journal of cell biology.

[80]  M. Frid,et al.  Hypoxia selectively induces proliferation in a specific subpopulation of smooth muscle cells in the bovine neonatal pulmonary arterial media. , 1995, The Journal of clinical investigation.

[81]  E. Krebs,et al.  The MAPK signaling cascade , 1995, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[82]  James M. Roberts,et al.  Inhibitors of mammalian G1 cyclin-dependent kinases. , 1995, Genes & development.

[83]  Michael C. Ostrowski,et al.  Cyclic AMP-dependent Activation of Rap1b (*) , 1995, The Journal of Biological Chemistry.

[84]  J. Avruch,et al.  Multiple independent inputs are required for activation of the p70 S6 kinase , 1995, Molecular and cellular biology.

[85]  N. Mons,et al.  Adenylyl cyclases and the interaction between calcium and cAMP signalling , 1995, Nature.

[86]  S. Elledge,et al.  p57KIP2, a structurally distinct member of the p21CIP1 Cdk inhibitor family, is a candidate tumor suppressor gene. , 1995, Genes & development.

[87]  J. Massagué,et al.  Cloning of p57KIP2, a cyclin-dependent kinase inhibitor with unique domain structure and tissue distribution. , 1995, Genes & development.

[88]  S. Marx,et al.  Rapamycin-FKBP inhibits cell cycle regulators of proliferation in vascular smooth muscle cells. , 1995, Circulation research.

[89]  E. Krebs,et al.  Inactivation of Glycogen Synthase Kinase-3 by Epidermal Growth Factor Is Mediated by Mitogen-activated Protein Kinase/p90 Ribosomal Protein S6 Kinase Signaling Pathway in NIH/3T3 Cells (*) , 1995, The Journal of Biological Chemistry.

[90]  J. Vane,et al.  Pharmacodynamic profile of prostacyclin. , 1995, The American journal of cardiology.

[91]  E. Van Obberghen,et al.  Regulation of the MAP kinase cascade in PC12 cells: B‐Raf activates MEK‐1 (MAP kinase or ERK kinase) and is inhibited by cAMP , 1995, FEBS letters.

[92]  J. Blenis,et al.  Activation of pp70/85 S6 kinases in interleukin-2-responsive lymphoid cells is mediated by phosphatidylinositol 3-kinase and inhibited by cyclic AMP , 1995, Molecular and cellular biology.

[93]  P. Roach,et al.  A secondary phosphorylation of CREB341 at Ser129 is required for the cAMP-mediated control of gene expression. A role for glycogen synthase kinase-3 in the control of gene expression. , 1994, The Journal of biological chemistry.

[94]  James M. Roberts,et al.  lnterleukin-2-mediated elimination of the p27Kipl cyclin-dependent kinase inhibitor prevented by rapamycin , 1994, Nature.

[95]  S. M. Van Patten,et al.  Multiple pathway signal tran sduction by the cAMP‐dependent protein kinase , 1994, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[96]  T. Hunter,et al.  Cyclins and cancer II: Cyclin D and CDK inhibitors come of age , 1994, Cell.

[97]  C. Sherr.  G1 phase progression: Cycling on cue , 1994, Cell.

[98]  Andrew P. Somlyo,et al.  Signal transduction and regulation in smooth muscle , 1994, Nature.

[99]  J. Massagué,et al.  Cyclic AMP-induced G1 phase arrest mediated by an inhibitor (p27 Kip1 ) of cyclin-dependent kinase 4 activation , 1994, Cell.

[100]  E. Avvedimento,et al.  A role for cAMP-dependent protein kinase in early embryonic divisions. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[101]  W. Kolch,et al.  Mechanism of inhibition of Raf-1 by protein kinase A , 1994, Molecular and cellular biology.

[102]  G. Johnson,et al.  B-Raf-dependent regulation of the MEK-1/mitogen-activated protein kinase pathway in PC12 cells and regulation by cyclic AMP , 1994, Molecular and cellular biology.

[103]  J. Parsons,et al.  Focal adhesion kinase and associated proteins. , 1994, Current opinion in cell biology.

[104]  B. Schaffhausen,et al.  The hunt for Ras targets , 1994, Nature.

[105]  U. Rapp,et al.  The Raf-1 serine/threonine protein kinase. , 1994, Seminars in cancer biology.

[106]  N. Tonks,et al.  PTP‐PEST: a protein tyrosine phosphatase regulated by serine phosphorylation. , 1994, The EMBO journal.

[107]  X. F. Zhang,et al.  Critical binding and regulatory interactions between Ras and Raf occur through a small, stable N-terminal domain of Raf and specific Ras effector residues , 1994, Molecular and cellular biology.

[108]  J. Maclouf,et al.  Regulation of cyclooxygenase-2 expression in aortic smooth muscle cells. , 1994, Arteriosclerosis and thrombosis : a journal of vascular biology.

[109]  G. Thomas,et al.  Rapamycin selectively represses translation of the "polypyrimidine tract" mRNA family. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[110]  E. Dennis.  Diversity of group types, regulation, and function of phospholipase A2. , 1994, The Journal of biological chemistry.

[111]  G. Johnson,et al.  Acetylcholine muscarinic m1 receptor regulation of cyclic AMP synthesis controls growth factor stimulation of Raf activity , 1994, Molecular and cellular biology.

[112]  K. Pritchard,et al.  Induction of cyclooxygenase-2 in rat vascular smooth muscle cells in vitro and in vivo. , 1994, The Journal of biological chemistry.

[113]  R. Iyengar,et al.  Suppression of Ras-induced transformation of NIH 3T3 cells by activated G alpha s. , 1994, Science.

[114]  E. Krebs,et al.  Insulin-like growth factor-I and platelet-derived growth factor-BB induce directed migration of human arterial smooth muscle cells via signaling pathways that are distinct from those of proliferation. , 1994, The Journal of clinical investigation.

[115]  E. Van Obberghen,et al.  Cyclic AMP activates the mitogen-activated protein kinase cascade in PC12 cells. , 1994, The Journal of biological chemistry.

[116]  J. Tavaré,et al.  Differentiation of PC12 cells in response to a cAMP analogue is accompanied by sustained activation of mitogen‐activated protein kinase , 1994, FEBS letters.

[117]  N. Sonenberg,et al.  Elevated levels of cyclin D1 protein in response to increased expression of eukaryotic initiation factor 4E , 1993, Molecular and cellular biology.

[118]  P. Dent,et al.  Inhibition of the EGF-activated MAP kinase signaling pathway by adenosine 3',5'-monophosphate. , 1993, Science.

[119]  S. Cook,et al.  Inhibition by cAMP of Ras-dependent activation of Raf. , 1993, Science.

[120]  J. Bos,et al.  cAMP antagonizes p21ras‐directed activation of extracellular signal‐regulated kinase 2 and phosphorylation of mSos nucleotide exchange factor. , 1993, The EMBO journal.

[121]  J. Lawrence,et al.  Increasing cAMP attenuates activation of mitogen-activated protein kinase. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[122]  E. Krebs,et al.  Protein kinase A antagonizes platelet-derived growth factor-induced signaling by mitogen-activated protein kinase in human arterial smooth muscle cells. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[123]  S. Elledge,et al.  Normal and oncogenic p21ras proteins bind to the amino-terminal regulatory domain of c-Raf-1 , 1993, Nature.

[124]  R. Davis,et al.  The mitogen-activated protein kinase signal transduction pathway. , 1993, The Journal of biological chemistry.

[125]  M. Reidy.  Neointimal Proliferation: The Role of Basic FGF on Vascular Smooth Muscle Cell Proliferation , 1993, Thrombosis and Haemostasis.

[126]  H. Lane,et al.  p70s6k function is essential for G1 progression , 1993, Nature.

[127]  R. Ross.  The pathogenesis of atherosclerosis: a perspective for the 1990s , 1993, Nature.

[128]  E. Villacres,et al.  The regulatory diversity of the mammalian adenylyl cyclases. , 1993, Current opinion in cell biology.

[129]  M. Hallett,et al.  Inhibition of proliferation, but not of Ca2+ mobilization, by cyclic AMP and GMP in rabbit aortic smooth-muscle cells. , 1992, The Biochemical journal.

[130]  J. Nevins,et al.  E2F: a link between the Rb tumor suppressor protein and viral oncoproteins. , 1992, Science.

[131]  J. Avruch,et al.  Rapamycin-induced inhibition of the 70-kilodalton S6 protein kinase. , 1992, Science.

[132]  G. Crabtree,et al.  Rapamycin-FKBP specifically blocks growth-dependent activation of and signaling by the 70 kd S6 protein kinases , 1992, Cell.

[133]  N. Ringertz,et al.  Adenosine receptors, cyclic AMP accumulation, and DNA‐synthesis in aortic smooth muscle cell cultures of adult and neonatal rats , 1992, Journal of cellular physiology.

[134]  G. Langer.  Calcium and the heart: exchange at the tissue, cell, and organelle levels 1 , 1992, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[135]  M. Rabinovitch.  Investigational approaches to pulmonary hypertension. , 1991, Toxicologic pathology.

[136]  D. Brautigan,et al.  Activation of membrane protein-tyrosine phosphatase involving cAMP- and Ca2+/phospholipid-dependent protein kinases. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[137]  J. Thyberg,et al.  Regulation of differentiated properties and proliferation of arterial smooth muscle cells. , 1990, Arteriosclerosis.

[138]  M. Lampugnani,et al.  Endothelial cell motility, integrin receptor clustering, and microfilament organization are inhibited by agents that increase intracellular cAMP. , 1990, Laboratory investigation; a journal of technical methods and pathology.

[139]  E. Lapetina,et al.  Rap1-B is phosphorylated by protein kinase A in intact human platelets. , 1990, Biochemical and biophysical research communications.

[140]  N. Sonenberg,et al.  Malignant transformation by a eukaryotic initiation factor subunit that binds to mRNA 5' cap , 1990, Nature.

[141]  J. Hershey.  Protein phosphorylation controls translation rates. , 1989, The Journal of biological chemistry.

[142]  P. Cohen,et al.  Regulation of protein phosphatase-1G from rabbit skeletal muscle. 1. Phosphorylation by cAMP-dependent protein kinase at site 2 releases catalytic subunit from the glycogen-bound holoenzyme. , 1989, European journal of biochemistry.

[143]  M. Montminy,et al.  Cyclic AMP stimulates somatostatin gene transcription by phosphorylation of CREB at serine 133 , 1989, Cell.

[144]  R. Alexander,et al.  Vasoconstriction: a new activity for platelet-derived growth factor. , 1986, Science.

[145]  R. van Wijk,et al.  Cell cycle-dependent inhibition of human vascular smooth muscle cell proliferation by prostaglandin E1. , 1985, Experimental cell research.

[146]  M J Davies,et al.  Thrombosis and acute coronary-artery lesions in sudden cardiac ischemic death. , 1984, The New England journal of medicine.

[147]  Tore Frängsmyr,et al.  Les Prix Nobel , 2000 .

[148]  W. K. Sonnenburg,et al.  Identification, quantitation, and cellular localization of PDE1 calmodulin-stimulated cyclic nucleotide phosphodiesterases. , 1998, Methods.

[149]  K. Kent,et al.  Smooth muscle cell migration and proliferation are mediated by distinct phases of activation of the intracellular messenger mitogen-activated protein kinase. , 1998, Journal of vascular surgery.

[150]  T. Haystead,et al.  PHAS proteins as mediators of the actions of insulin, growth factors and cAMP on protein synthesis and cell proliferation. , 1997, Advances in enzyme regulation.

[151]  P. Sassone-Corsi,et al.  Coupling signalling pathways to transcriptional control: nuclear factors responsive to cAMP. , 1997, Recent progress in hormone research.

[152]  J. Scott,et al.  Anchoring and scaffold proteins for kinases and phosphatases. , 1997, Recent progress in hormone research.

[153]  C. Leffler,et al.  Dilator prostanoid-induced cyclic AMP formation and release by cerebral microvascular smooth muscle cells: inhibition by indomethacin. , 1995, The Journal of pharmacology and experimental therapeutics.

[154]  J. Cavadore,et al.  Implications for cAMP-dependent protein kinase in the maintenance of the interphase state. , 1995, Progress in cell cycle research.

[155]  T. Lincoln,et al.  cGMP signaling through cAMP- and cGMP-dependent protein kinases. , 1995, Advances in pharmacology.

[156]  P. Sassone-Corsi,et al.  Transcription factors responsive to cAMP. , 1995, Annual review of cell and developmental biology.

[157]  M. Liscovitch.  Signal-activated phospholipases , 1994 .

[158]  R. Ross,et al.  Smooth muscle cells and the pathogenesis of the lesions of atherosclerosis. , 1993, British heart journal.

[159]  M. Houslay,et al.  Isolation and characterization of insulin-stimulated, high-affinity cAMP phosphodiesterases from rat liver. , 1988, Methods in enzymology.

[160]  E. Krebs,et al.  Phosphorylation-dephosphorylation of enzymes. , 1979, Annual review of biochemistry.

[161]  E. Sutherland,et al.  The regulatory role of adenosine-3', 5'-phosphate. , 1961, Cold Spring Harbor symposia on quantitative biology.

[162]  E. Van Obberghen,et al.  Printed in U.S.A. Copyright © 1997 by The Endocrine Society The Effect of Cyclic Adenosine Monophosphate on the Mitogen-Activated Protein Kinase Pathway Depends on Both the Cell Type and the Type of Tyrosine Kinase-Receptor* , 2022 .